Pathogenesis, clinical characteristics and personalized managements of multiple myeloma with chromosome 1 abnormalities

Pan Zhou,Weiya Li,Suqiong Zuo,Rongjun Ma,Xiaoli Yuan,Zunmin Zhu
DOI: https://doi.org/10.1080/10428194.2023.2216325
2023-06-11
Abstract:Multiple myeloma (MM) is a biologically heterogeneous malignancy defined by the proliferation of monoclonal plasma cells. Despite the tremendous advancement in MM treatment over the past decades, relapse remains a major problem which is inevitable for most patients. In particular, a partial of patients with early relapse and poor outcomes are classified as a high-risk group. Apart from the clinical stage, genetic aberrations are now recognized as important prognostic factors for identifying high-risk patients. Chromosome 1 abnormalities (C1As), particularly 1q21 gain or amplification, have been identified as common genetic aberrations in patients with MM and are often considered unfavorable prognostic markers for progression-free survival and overall survival. However, more effective therapeutic approaches are still needed to overcome the negative impact of C1As. Therefore, we summarize the prevalence, pathogenesis, clinical significance and present therapeutic condition of C1As in MM, and attempt to conclude the precise and personalized management for patients with C1As.
oncology,hematology
What problem does this paper attempt to address?